Solutions
Beacon Database Solutions

Access exclusive datasets of pre-clinical, clinical and commercial data for complex therapeutics.

Complete with granular proprietary ontologies for precision searching and filtering.
Modalities

ADC

Bispecific

DDR

Cell Therapy

Cancer Vaccine

Microbiome

Gene Therapy

Checkpoint

Oncolytic Viruses

RNA

Cytokine

TPD
Disease Areas

Oncology

Neuroscience

Neurology

CVRM

Psychiatric

Autoimmune
Consulting
Life Science Market Research & Consulting

Beacon Consulting is Beacon’s strategic market research and scientific consulting team.
Market Research & Consulting

About Beacon Consulting

Data Analysis & Consulting

Market Research
Services
Beacon Services

Beacon APIs enable you to integrate Beacon data into your internal systems and dashboards.
APIs

Technology Plus

Benchmarking & Pipeline Prioritization

Client Finder

Competitive Landscape

Service Alignment

Strategic Partnerships, Licensing & Acquisitions

API Use Cases
Data
Beacon Data

Beacon data is manually curated by sector specialist analysts, to ensure unrivalled accuracy and comprehensiveness.
Our Data

Drug Data

Trial Data

Company Data

Deal Data

Patent Data
Who We Help
Who is Beacon For?

Beacon delivers decision-grade drug development intelligence for organizations and teams across the drug development life cycle.
By Organization

Big Pharma

Biotechs

Investors
By Role / Team

Business Development

Clinical Development

Research Scientists

Senior Leadership
Resources
Beacon Resources

Our resources offer strategic insight into the drug, trial and commercial landscape of multiple therapeutic and disease areas.

ALL RESOURCES
Resources

Blogs

Citations

Conference Reports

Infographics

Landscape Reviews

Market Reports

Webinars

Request Demo

Recent Highlights in the Discovery and Design of Antibody-Drug Conjugates

Garcia-Barrantes & Junutula

Recent Highlights in the Discovery and Design of Antibody-Drug Conjugates.

J.Med.Chem 69 16118 PMID: 42390077

Back to Citations View Publication